Where Does Wall Street Think Eloxx Pharmaceuticals Inc (ELOX) Stock Will Go?

Thursday, April 21, 2022 12:04 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Wall Street Think Eloxx Pharmaceuticals Inc (ELOX) Stock Will Go?

Analysts who follow Eloxx Pharmaceuticals Inc (ELOX) on average expect it to add 619.05% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns the stock an Analyst Ranking of 59, which means it ranks higher than 59 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating ELOX a Strong Buy today. Find out what this means to you and get the rest of the rankings on ELOX!

See Full ELOX Report

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Eloxx Pharmaceuticals Inc Stock Today?

Eloxx Pharmaceuticals Inc (ELOX) stock is unchanged -1.17% while the S&P 500 is higher by 0.15% as of 11:49 AM on Thursday, Apr 21. ELOX is unchanged $0.00 from the previous closing price of $0.42 on volume of 254,821 shares. Over the past year the S&P 500 is higher by 7.01% while ELOX has fallen -82.57%. ELOX lost -$0.95 per share the over the last 12 months. Click Here to get the full Stock Report for Eloxx Pharmaceuticals Inc stock.